Cargando…

Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis

AIM: To test if the treatment adherence to branched-chain amino acid (BCAA) granules influences the serum albumin level and prognosis in prospective 2984 patients with decompensated liver cirrhosis who were prescribed BCAA granules containing 952 mg of L-isoleucine, 1904 mg of L-leucine and 1144 mg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takaguchi, Koichi, Moriwaki, Hisataka, Doyama, Hisashi, Iida, Masayuki, Yagura, Michiyasu, Shimada, Noritomo, Kang, Masahiro, Yamada, Haruki, Kumada, Hiromitsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708103/ https://www.ncbi.nlm.nih.gov/pubmed/23046471 http://dx.doi.org/10.1111/j.1872-034X.2012.01097.x

Ejemplares similares

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin
por: Toyoda, Hidenori, et al.
Publicado: (2012)

Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy
por: Inoue, Takako, et al.
Publicado: (2017)

Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report
por: Iida, Hiroya, et al.
Publicado: (2020)

Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naïve Genotype 1b Chronic Hepatitis C Patients
por: Abe, Hiroshi, et al.
Publicado: (2014)

Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients
por: Setoyama, Hiroko, et al.
Publicado: (2016)

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib
por: Tada, Toshifumi, et al.
Publicado: (2021)

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study
por: Izumi, Namiki, et al.
Publicado: (2012)

Pseudocholinesterase and albumin in infants with cirrhosis
por: Popoviê, LJ, et al.
Publicado: (2000)

The efficacy of branched-chain amino acid granules to restore phagocytic activity in cirrhosis patients, a randomized controlled trial
por: Chamroonkul, Naichaya, et al.
Publicado: (2023)

C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib
por: Tada, Toshifumi, et al.
Publicado: (2022)

Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response
por: Toyoda, Hidenori, et al.
Publicado: (2021)

Human albumin in the management of complications of liver cirrhosis
por: Bernardi, Mauro, et al.
Publicado: (2012)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Transition in the etiology of liver cirrhosis in Japan: a nationwide survey
por: Enomoto, Hirayuki, et al.
Publicado: (2019)

The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan
por: Hatanaka, Takeshi, et al.
Publicado: (2022)

Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis
por: Wilde, Benjamin, et al.
Publicado: (2019)

Role of albumin in cirrhosis: from a hospitalist’s perspective
por: Walayat, Saqib, et al.
Publicado: (2017)

The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan
por: Toyoda, Hidenori, et al.
Publicado: (2019)

Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment
por: Chuma, Makoto, et al.
Publicado: (2022)

Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome
por: Fujiyama, Shunichiro, et al.
Publicado: (2017)

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015)

Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis
por: Basili, Stefania, et al.
Publicado: (2019)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
por: Grüngreiff, Kurt, et al.
Publicado: (2021)

Albumin administration in patients with cirrhosis: Current role and novel perspectives
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2022)

Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis
por: Kugelmas, Marcelo, et al.
Publicado: (2023)

Identification of indications for albumin administration in septic patients with liver cirrhosis
por: Hu, Wenhan, et al.
Publicado: (2023)

S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis
por: Tsuji, Kunihiro, et al.
Publicado: (2017)

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2018)

GRANULES IN THE CELLS OF CHICK EMBRYOS PRODUCED BY EGG ALBUMIN IN THE MEDIUM OF TISSUE CULTURES
por: Lewis, Margaret Reed
Publicado: (1921)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2019)

Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
por: Baldassarre, Maurizio, et al.
Publicado: (2021)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

Effective albumin – A novel paradigm in the management of decompensated liver cirrhosis
por: Bernardi, Mauro
Publicado: (2023)

Use of albumin infusion for cirrhosis-related complications: An international position statement
por: Bai, Zhaohui, et al.
Publicado: (2023)

Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis
por: Yao, Junjie, et al.
Publicado: (2023)

Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
por: Shimizu, Masahito, et al.
Publicado: (2008)

Aberrant Right Posterior Hepatic Duct
por: Mori, Haruki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q68jkus1lqc0ujd99n4srjmq2a